Design Therapeutics, Inc. (DSGN)
NASDAQ: DSGN · Real-Time Price · USD
12.81
0.00 (0.00%)
At close: Apr 28, 2026, 4:00 PM EDT
12.81
0.00 (0.00%)
After-hours: Apr 28, 2026, 4:04 PM EDT
Design Therapeutics Employees
Design Therapeutics had 54 employees as of December 31, 2025. The number of employees did not change compared to the previous year.
Employees
54
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,292,444
Market Cap
790.02M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| MeiraGTx Holdings | 403 |
| Kura Oncology | 260 |
| ARS Pharmaceuticals | 163 |
| Allogene Therapeutics | 152 |
| Absci | 140 |
| Cullinan Therapeutics | 109 |
| Vor Biopharma | 76 |
| Crescent Biopharma | 44 |
DSGN News
- 1 hour ago - Design Therapeutics Announces First Quarter 2026 Financial Results and Recent Business Updates - GlobeNewsWire
- 7 weeks ago - Design Therapeutics Transcript: Leerink Global Healthcare Conference 2026 - Transcripts
- 7 weeks ago - Design Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Recent Business Updates - GlobeNewsWire
- 2 months ago - Design Therapeutics Transcript: Oppenheimer 36th Annual Healthcare Life Sciences Conference - Transcripts
- 2 months ago - Design Therapeutics to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 5 months ago - Design Therapeutics Transcript: Evercore ISI 8th Annual HealthCONx Conference - Transcripts
- 5 months ago - Design Therapeutics Transcript: Piper Sandler 37th Annual Healthcare Conference - Transcripts
- 6 months ago - Design Therapeutics Announces Plans to Initiate Patient Dosing of DT-818 in Myotonic Dystrophy Type-1 (DM1) in the First Half of 2026 and Reports Third Quarter 2025 Financial Results - GlobeNewsWire